SGP Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
0
0
Cost of Revenue
0
0
Gross Profit
0
0
Operating Expenses
22.0M
+42.6%
15.4M
R&D
10.9M
+28.1%
8.5M
SG&A
11.0M
+60.6%
6.9M
Operating Income
-21967000
-42.6%
-15409000
EBITDA
-21625000
-43.3%
-15091000
Net Income
-19864000
-43.8%
-13818000
EPS (Basic)
$-0.59
+14.5%
$-0.69
EPS (Diluted)
$-0.59
+14.5%
$-0.69
Shares (Diluted)
33.4M
+67.8%
19.9M
SpyGlass Pharma (SGP) โ€” Financials